tiprankstipranks
Trending News
More News >

Fred Aslan Insider Profile

4 Followers
Fred Aslan, President & CEO, Director at Artiva Biotherapeutics, Inc., holds 382.22K shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV).
tipranks
Fred Aslan

Fred Aslan
Artiva Biotherapeutics, Inc. (ARTV)
President & CEO, Director

Not Ranked
Fred Aslan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Fred Aslan's holdings

Insider Roles

Artiva Biotherapeutics, Inc.
(ARTV)
President & CEO, Director
Roles that Fred Aslan holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Fred Aslan

Fred Aslan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Artiva Biotherapeutics, Inc.
Aug 18, 2025
President & CEO, Director
Uninformative Sell
69.36K
$1.02M
Fred Aslan has not reported any informative transactions for ARTV, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 22, 2024
Uninformative Buy
$0.00
-
$0.00
Mar 07, 2025
Uninformative Buy
$0.00
-
$0.00
Aug 18, 2025
Uninformative Sell
$69.36K
-
$2.72
Aug 18, 2025
Uninformative Sell
$21.82K
-
$2.44
List of latest transactions for each holding click on a transaction to see Fred Aslan's performance on stock

Fred Aslan insider profile FAQ

What is the percentage of profitable transactions made by Fred Aslan?
The percentage of profitable transactions made by Fred Aslan is ―.
    What is the average return per transaction made by Fred Aslan?
    The average return per transaction made by Fred Aslan is ―.
      What stocks does Fred Aslan hold?
      Fred Aslan holds: ARTV stocks.
        What was Fred Aslan’s latest transaction?
        Fred Aslan latest transaction was an Uninformative Sell of $69.36K.
          What was Fred Aslan's most profitable transaction?
          Fred Aslan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Fred Aslan's role in Artiva Biotherapeutics, Inc.?
            Fred Aslan's role in Artiva Biotherapeutics, Inc. is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.